MONTREAL, Oct. 16, 2023 (GLOBE NEWSWIRE) Knight Therapeutics Inc., (TSX: GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltd., has received pricing approval for Minjuvi® (tafasitamab) from the Drugs Market Regulation Chamber (“CMED”). As a result, Knight expects to launch Minjuvi® in Brazil in the second quarter of 2024. In July 2023, ANVISA (Agência Nacional de Vigilância Sanitária) granted Market Authoriz
Knight Therapeutics Announces Regulatory Submission of Pemigatinib in Brazil streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
MONTREAL, Oct. 10, 2023 (GLOBE NEWSWIRE) Knight Therapeutics Inc., (TSX:GUD) ("Knight") a pan-American (ex-USA) specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical
MONTREAL, Oct. 10, 2023 Knight Therapeutics Inc., a pan-American specialty pharmaceutical company, announced today that its Brazilian affiliate, United Medical Ltd., has submitted a marketing.